• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

986
82
61
58
47

COUNTRY

56
19
10
7
5

CATEGORIES

  • 85
  • 124
  • 66
  • 65
  • 37
  • 36
  • 12
  • 12
  • 12
  • 18

PRICE

551
816
1,695
2,678

PUBLISHED

27
292
660
2,678

PRODUCT TYPE

2,574
84
12
7
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Anaplastic Thyroid Cancer - Pipeline Review, H2 2013

Anaplastic Thyroid Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Anaplastic Thyroid Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Metastatic Prostate Cancer - Pipeline Review, H2 2013

Metastatic Prostate Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Prostate Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

August 2013
FROM

Prostate Cancer - Pipeline Review, H2 2013

Prostate Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Prostate Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Cervical Cancer - Pipeline Review, H2 2013

Cervical Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM
Disease and Therapy Review: Ovarian Cancer Disease and Therapy Review: Ovarian Cancer - Product Thumbnail Image

Disease and Therapy Review: Ovarian Cancer

The Ovarian Cancer Disease and Therapy Review provides an overview of ovarian cancerm, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, as well as information...

August 2013
FROM
Disease and Therapy Review: Ovarian Cancer Disease and Therapy Review: Ovarian Cancer - Product Thumbnail Image

Disease and Therapy Review: Ovarian Cancer

The Ovarian Cancer Disease and Therapy Review provides an overview of ovarian cancerm, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, as well as information...

August 2013
FROM
Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors - Product Thumbnail Image

Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors

Product description The present Competitive Intelligence report about Bruton’s Tyrosine Kinase (BTK) Inhibitorsprovides a competitor evaluation in the field of small molecule-based inhibitors of Bruton’s...

August 2013
FROM

OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2017 Summary Acute myeloid (myelogenous, myelocytic) leukemia is a rapidly progressing blood cancer with a...

August 2013
FROM
Competitor Analysis: Focal Adhesion Kinase (FAK) Inhibitors Competitor Analysis: Focal Adhesion Kinase (FAK) Inhibitors - Product Thumbnail Image

Competitor Analysis: Focal Adhesion Kinase (FAK) Inhibitors

The present Competitive Intelligence report about Focal Adhesion Kinase (FAK) Inhibitors provides a competitor evaluation in the field of small molecule-based inhibitors of Focal Adhesion Kinase (FAK)...

August 2013
FROM

Global Stem Cell Anticancer Therapeutics Market 2012-2016

The analysts forecast the Global Stem Anticancer Therapeutics market to grow at a CAGR of 11 48 percent over the period 2012-2016 Increasing investment in R&D is one of the key factors contributing...

August 2013
FROM
Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors - Product Thumbnail Image

Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

Product description The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competitor evaluation in the field of small molecule and antibody-based inhibitors...

August 2013
FROM
Pathway Analyzer for the Rational Application and Combinations of Protein Kinase Inhibitor Drugs in Oncology: From Bench to Bedside Pathway Analyzer for the Rational Application and Combinations of Protein Kinase Inhibitor Drugs in Oncology: From Bench to Bedside - Product Thumbnail Image

Pathway Analyzer for the Rational Application and Combinations of Protein Kinase Inhibitor Drugs in Oncology: From Bench to Bedside

Protein kinases are key regulators of cell function that constitute one of the largest and most functionally diverse gene families with approximately 518 kinases encoded by the human genome. They direct...

August 2013

Cancer Monoclonal Antibodies Market Forecast to 2017

Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020 The dramatic increase in the size of...

August 2013
FROM

Ovarian Cancer Pipeline Analysis

“Ovarian Cancer Pipeline Analysis” gives a comprehensive insight into the various drug profiles being developed for the treatment of Ovarian Cancer This research report covers all the ongoing drug development...

August 2013
FROM

Topics in Anti-Cancer Research - Volume 2

This is the second volume of the Patent eBook Series titled Topics in Anti-Cancer Research The eBook includes updated chapters on topics relevant to contemporary cancer research published in the journal,...

August 2013

Pancreatic Cancer Drug Pipeline Analysis

"“Pancreatic Cancer Drug Pipeline Analysis” gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer This research report covers all the ongoing...

August 2013
FROM

Stereotactic Body Radiation Therapy: Lung Cancer

The ten chapters of this book provide a concise overview of the various aspects of stereotactic body radiation therapy for non-small-cell lung cancer (NSCLC), including general, radiobiological, technical...

August 2013
Personalized Management of Lung Cancer Personalized Management of Lung Cancer - Product Thumbnail Image

Personalized Management of Lung Cancer

Lung cancer remains the leading cause of death from cancer in developed countries worldwide. Current efforts in combating lung cancer focus on the development of therapies tailored to each individual...

August 2013

Follicular Lymphoma - Pipeline Review, H2 2013

Follicular Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Follicular Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Renal Insufficiency - Pipeline Review, H2 2013

Renal Insufficiency - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Renal Insufficiency - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)